CA2666689A1 - Medical device coatings and coated stents - Google Patents

Medical device coatings and coated stents Download PDF

Info

Publication number
CA2666689A1
CA2666689A1 CA002666689A CA2666689A CA2666689A1 CA 2666689 A1 CA2666689 A1 CA 2666689A1 CA 002666689 A CA002666689 A CA 002666689A CA 2666689 A CA2666689 A CA 2666689A CA 2666689 A1 CA2666689 A1 CA 2666689A1
Authority
CA
Canada
Prior art keywords
stent
ap4a
medical device
coating
coated stents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002666689A
Other languages
English (en)
French (fr)
Inventor
Paul Zamecnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2666689A1 publication Critical patent/CA2666689A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
CA002666689A 2006-10-24 2007-10-24 Medical device coatings and coated stents Abandoned CA2666689A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86264006P 2006-10-24 2006-10-24
US60/862,640 2006-10-24
PCT/US2007/082323 WO2008063806A2 (en) 2006-10-24 2007-10-24 Medical device coatings and coated stents

Publications (1)

Publication Number Publication Date
CA2666689A1 true CA2666689A1 (en) 2008-05-29

Family

ID=39430426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002666689A Abandoned CA2666689A1 (en) 2006-10-24 2007-10-24 Medical device coatings and coated stents

Country Status (4)

Country Link
EP (1) EP2076210A2 (enExample)
JP (1) JP2010507466A (enExample)
CA (1) CA2666689A1 (enExample)
WO (1) WO2008063806A2 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049550A (en) * 1987-11-05 1991-09-17 Worcester Foundation For Experimental Biology Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents
JP2783880B2 (ja) * 1989-11-24 1998-08-06 富士レビオ株式会社 心臓病治療剤
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound

Also Published As

Publication number Publication date
JP2010507466A (ja) 2010-03-11
EP2076210A2 (en) 2009-07-08
WO2008063806A3 (en) 2008-11-06
WO2008063806A2 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
EP1454642B1 (en) Stent with phenoxy primer coating
US7682387B2 (en) Drug-delivery endovascular stent and method for treating restenosis
EP1549276B1 (en) Drug eluting coatings for medical implants
US8257729B2 (en) Implants with membrane diffusion-controlled release of active ingredient
US7323189B2 (en) Liquid and low melting coatings for stents
CN102083397B (zh) 具有生物可吸收层的支架
US10232092B2 (en) Stents and other devices having extracellular matrix coating
CA2794704C (en) Stents having controlled elution
JP3476604B2 (ja) 薬剤を付着・コーティングしたステントの製造方法
US8518097B2 (en) Plasticized stent coatings
US7144419B2 (en) Drug-polymer coated stent with blended phenoxy and styrenic block copolymers
US20040024450A1 (en) Drug-delivery endovascular stent and method for treating restenosis
ES2926865T3 (es) Endoprótesis de elución de fármaco con una capa de liberación biodegradable fijada con un recubrimiento de imprimación electroinjertado
EP1440698A1 (en) Drug-polymer coated stent with pegylated styrenic block polymers
JP2007512103A (ja) 生体腐食性のポリエステルを含む、埋め込み型用具のためのコーティング及びその製造方法
JP2009506869A (ja) 修飾ポリイミン由来一酸化窒素放出ポリマー
JP2009505727A (ja) 医療機器及びそのコーティングとして有益な一酸化窒素放出生分解性ポリマー
EP1861070B1 (en) Drugs with improved hydrophobicity for incorporation in medical devices
EP1440699A1 (en) Stent with epoxy primer coating
US20100286765A1 (en) Medical Device Coatings and Coated Stents
CA2666689A1 (en) Medical device coatings and coated stents
CN121175082A (zh) 支架多涂层
WO2006044989A1 (en) Devices and methods for delivery of pimecrolimus and other therapeutic agents
HK1156494B (en) Drug-delivery endovascular stent
HK1156494A1 (en) Drug-delivery endovascular stent

Legal Events

Date Code Title Description
FZDE Discontinued